Anticoagulation therapy for dialysis patients

Anticoagulation therapy for dialysis patients - Anticoagulation therapy for dialysis patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000060009

Enrollment

6000

Registered

2025-12-08

Start date

2020-01-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dialysis patients

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: maintenance dialysis patients affiliated with the institutions participating Hyogo association of dialysis physicians

Exclusion criteria

Exclusion criteria: patients refusing to participate this study patients with insufficient data

Design outcomes

Primary

Measure	Time frame
all cause death cardiovascular death death from ischemic heart disease death from hemorrhage hemorrhagic cardiovascular death	—

Secondary

Measure	Time frame
cerebral infarction ishcemic heart disease heart failure peripheral artery disease vascular access failure systemic thrombosis cerebral hemorrhage gasterointestinal hemorrhage severe systemic hemorrhage	—

Countries

Japan

Contacts

Public ContactKeiji Kono

Kobe university graduate school of medicine Division of Nephrology

kkono@med.kobe-u.ac.jp078-382-6500

Outcome results